Patients with schizophrenia must take medication regularly to reduce their risk of relapse. But the disease impairs memory, according to new research, meaning these patients may have difficulty in remembering to take their tablets. Medical Letter on the CDC & FDA via NewsEdge Corporation : Patients with schizophrenia must take medication regularly to reduce their risk of relapse. But the disease impairs memory, according to new research, meaning these patients may have difficulty in remembering to take their tablets. Habitual tasks, like taking medicine every few hours, rely on "prospective memory". This type of memory, which appears to be impaired by schizophrenia, enables you to remember that you have to do something in the future, without being prompted. Brita Elvevag, from the Clinical Brain Disorders Branch of the U.S. National Institute of Mental Health and her colleagues who carried out the research published in BMC Psychiatry, wrote, "To our knowledge this is the first study to show that schizophrenia is associated with an overall impairment in habitual prospective memory performance". The authors hypothesized that patients with schizophrenia would have problems with tasks requiring prospective memory. They might mistake remembering they have to do something with remembering they've actually done it. Their hypothesis stemmed from the theory that people with schizophrenia confuse real and imagined events. To test their hypothesis the researchers, based at NIMH and the University of Warwick, compared the prospective memory of people with and without the disease. In each test participants maneuvered a ball around an obstacle course for 90 seconds. They were asked to turn over a counter when they were at least 25 seconds into the test. The time delay ensured that prospective memory had to be used. Participants with schizophrenia were more likely to forget to turn over the counter. At the end of the test the participants were asked if they had remembered to turn over the counter. Approximately a third of the time participants with schizophrenia reported they had done so when they had not. Elvevag and colleagues wrote, "This would seem a worryingly high probability for such an apparently simple task that posed few problems for control participants. ... Our result suggests that patients' self-reports of having completed a habitual prospective memory task, for example taking medication, are likely to be particularly unreliable". Schizophrenia affects one in every hundred people at some point during their lives. While there is no cure, it is treatable with antipsychotic drugs. About 80% of those patients who stop taking their medications after an acute episode of schizophrenia will have a relapse within a year (Elvevag B, Maylor EA, Gilbert AL. Habitual prospective memory in schizophrenia. BMC Psychiatry, 2003;3:9). This article was prepared by Medical Letter on the CDC & FDA editors from staff and other reports. <> << Copyright ©2003 NewsRx.com >>
VII Российский конгресс с международным участием «Молекулярные основы клинической медицины – возможное и реальное» пройдет в Санкт-Петербурге 16 декабря, 2024
Ведущий научный сотрудник НЦПЗ Ирина Федоровна Рощина награждена медалью Г.И. Челпанова 10 декабря, 2024
